湖南师范大学学报（医学版）
湖南師範大學學報（醫學版）
호남사범대학학보（의학판）
JOURNAL OF HUNAN NORMAL UNIVERSITY(MEDICAL SCIENCE)
2013年
1期
83-85
,共3页
终末期肾病%血液透析%一体化治疗
終末期腎病%血液透析%一體化治療
종말기신병%혈액투석%일체화치료
end-stage renal disease (ESRD)%hemodialysis%intergration treatment
目的：观察一体化治疗对慢性肾病的临床治疗效果。方法：选择2010~2012年来我院进行首次血液透析的终末期肾病患者125例分为二组，A组为在进行血液透析前未进行一体化治疗，B组患者透析前进行了一体化治疗，观察CO2CP,Scr,Ccr,Hb,Alb,血P、血Ca,收缩压和舒张压变化，及透析时并发症发生情况。结果：A组患者在营养治疗，肾性贫血的纠正，监测甲状旁腺激素及调节钙磷平衡，血压控制等方面均不如B组患者(P<0.05)；与B组比较，A组患者的贫血、代谢性酸中毒、钙磷代谢紊乱、低白蛋白血症明显，急诊透析多，血压控制不理想(P<0.05)。结论：通过对慢性肾脏病患者一体化治疗的管理，患者延缓进入透析的时间且并发症明显减少，替代治疗的血管通路充分，患者生存率和生活质量得以提高。
目的：觀察一體化治療對慢性腎病的臨床治療效果。方法：選擇2010~2012年來我院進行首次血液透析的終末期腎病患者125例分為二組，A組為在進行血液透析前未進行一體化治療，B組患者透析前進行瞭一體化治療，觀察CO2CP,Scr,Ccr,Hb,Alb,血P、血Ca,收縮壓和舒張壓變化，及透析時併髮癥髮生情況。結果：A組患者在營養治療，腎性貧血的糾正，鑑測甲狀徬腺激素及調節鈣燐平衡，血壓控製等方麵均不如B組患者(P<0.05)；與B組比較，A組患者的貧血、代謝性痠中毒、鈣燐代謝紊亂、低白蛋白血癥明顯，急診透析多，血壓控製不理想(P<0.05)。結論：通過對慢性腎髒病患者一體化治療的管理，患者延緩進入透析的時間且併髮癥明顯減少，替代治療的血管通路充分，患者生存率和生活質量得以提高。
목적：관찰일체화치료대만성신병적림상치료효과。방법：선택2010~2012년래아원진행수차혈액투석적종말기신병환자125례분위이조，A조위재진행혈액투석전미진행일체화치료，B조환자투석전진행료일체화치료，관찰CO2CP,Scr,Ccr,Hb,Alb,혈P、혈Ca,수축압화서장압변화，급투석시병발증발생정황。결과：A조환자재영양치료，신성빈혈적규정，감측갑상방선격소급조절개린평형，혈압공제등방면균불여B조환자(P<0.05)；여B조비교，A조환자적빈혈、대사성산중독、개린대사문란、저백단백혈증명현，급진투석다，혈압공제불이상(P<0.05)。결론：통과대만성신장병환자일체화치료적관리，환자연완진입투석적시간차병발증명현감소，체대치료적혈관통로충분，환자생존솔화생활질량득이제고。
Objective To observe the integrated treatment of clinical treatment of chronic kidney disease. Methods 2010 to 2012 to our hospital for the first time on hemodialysis ESRD patients 125 were divided into two groups, A group integration during hemodialysis treatment, patients in group B integrated pre-dialysis treatment , observed CO2CP, Scr, Ccr, Hb, Alb, blood P, blood Ca, systolic and diastolic blood pressure, and dialysis compli-cations. Results A group of patients in nutritional therapy, renal anemia corrected, parathyroid hormone monitor-ing and regulation of calcium and phosphorus balance, blood pressure control are not as good as the patients in group B (P<0.05);compared with group B, patients in group A anemia, metabolic acidosis, calcium and phospho-rus metabolism, hypoalbuminemia, emergency dialysis, blood pressure control (P<0.05). Conclusion Through the the management integrated treatment of chronic kidney disease patients delay the time to dialysis and reduce complications, full replacement therapy vascular access, patient survival and quality of life can be improved.
